We found that the application of cholesterol depletion through MβCD in mice not only restricts cancer cell survival and aggressiveness relative to cholesterol levels but also engages the STING agonist-driven anti-tumor response as well as checkpoint blockage. This evidence concerns the gene STING1 and neoplasm.